Recently, the China Chest Pain Center Headquarters issued the “Notice on the Results of the Third Batch of 2023 and the First Batch of 2024 Chest Pain Center Re-Accreditations.” After a rigorous review by the China Chest Pain Center Headquarters, the Chest Pain Center of Hebei Yiling Hospital successfully passed the “National Chest Pain Center Re-Accreditation.” This marks another national recognition of Hebei Yiling Hospital’s capabilities and service standards in treating patients with chest pain.

The “Chest Pain Center” is a concept aimed at reducing the incidence and mortality of acute myocardial infarction. Through multidisciplinary collaboration, it provides rapid and accurate diagnosis, risk assessment, and appropriate treatment methods, enabling effective stratified treatment of chest pain patients. This improves early diagnosis and treatment of acute coronary syndrome (ACS), reduces the likelihood or prevents the occurrence of myocardial infarction, and accurately screens low-risk myocardial ischemia patients. The goal is to reduce misdiagnosis, missed diagnosis, and overtreatment, thereby improving patients’ clinical prognosis.

The re-accreditation review process was strict and comprehensive, covering multiple aspects including the Chest Pain Center’s organizational structure, personnel qualifications, treatment procedures, equipment and facilities, and quality control. The hospital’s Chest Pain Center team, relying on solid professional knowledge, rich clinical experience, and a strong sense of responsibility, actively met all review requirements and continuously optimized every detail of their work. Under the guidance of experts from the Hebei Province Chest Pain Center Alliance and with strong support from hospital leadership, the team successfully passed the re-accreditation, which is a powerful affirmation of the hospital’s achievements in building its Chest Pain Center.
In September 2020, Hebei Yiling Hospital successfully passed the China Chest Pain Center (Standard Version) certification, marking that the hospital’s comprehensive treatment capability for acute chest pain patients reached the national standard level. Since the establishment of the Chest Pain Center, Hebei Yiling Hospital has adhered to the philosophy that “time is myocardium, time is life,” continuously optimizing treatment processes and integrating multidisciplinary resources including the Emergency Department, Cardiovascular Department, Catheterization Lab, Imaging Department, and Ultrasound Department. This has formed a well-trained, rapid-response chest pain treatment team and built a “fast lane” for treating acute chest pain patients, providing the fastest, standardized, and most accurate treatment for high-risk acute chest pain patients. At the same time, by strengthening seamless connection between pre-hospital emergency care and in-hospital treatment, the time from onset to effective treatment for acute chest pain patients has been minimized, greatly improving treatment success rates and reducing patient mortality and disability rates.
Additionally, the hospital has strengthened cooperation with primary care hospitals to establish a regional chest pain treatment network. The regional collaborative treatment system and treatment capabilities have been further enhanced. The D2W time (door-to-wire time, from patient arrival to guidewire passage) for acute myocardial infarction patients has been shortened from an average of 86.2 minutes at the initial stage to 56.5 minutes on average, with the shortest time as low as 23 minutes. This has secured precious “golden time” for acute myocardial infarction patients and provided life and health protection for acute chest pain patients in Shijiazhuang and surrounding areas.
With strong attention from hospital leadership, the Chest Pain Center organizes weekly chest pain meetings every Monday afternoon, quarterly quality analysis meetings and typical case discussions, and biannual joint meetings. Regular emergency drills for chest pain patients are conducted, and improvement measures are promptly formulated to address identified issues. Through multidisciplinary collaboration, the center achieves accurate and rapid diagnosis, enhances early diagnosis and treatment capabilities for chest pain patients, reduces misdiagnosis and missed diagnosis, and avoids insufficient or excessive treatment. This ultimately saves lives, lowers mortality rates among chest pain patients, and improves prognosis.
Meanwhile, the hospital actively carries out public awareness campaigns on chest pain knowledge to improve public recognition of chest pain diseases and self-rescue abilities. The hospital consistently maintains routine ACS follow-up work and was listed on the 2024 Chest Pain Center Follow-up Potential Ranking, creating favourable conditions for early identification and timely treatment of chest pain patients.
Moreover, Hebei Yiling Hospital’s Chest Pain Center has innovatively implemented the “Four Alls and One Integration Model,” which includes full staff participation, full-process management, full-time control, full-area coverage, and integration of Chinese and Western medicine. Based on the collateral-disease theory and Ying-Wei theory guiding cardiovascular event chain intervention research, pilot clinical collaboration for major difficult diseases (acute myocardial infarction) combining Chinese and Western medicine, and the Hebei Province Clinical Medical Research Center for Traditional Chinese Medicine Cardiovascular Diseases, the hospital strengthens the construction of the Fuwai Hospital Cardiovascular Diagnosis and Treatment Base and explores a new model for building a chest pain center integrating Chinese and Western medicine.
Passing the chest pain center re-accreditation is an affirmation of the work of Hebei Yiling Hospital’s Chest Pain Center. The hospital will take this re-accreditation as an opportunity to further strengthen the construction and management of the Chest Pain Center, continuously optimize treatment processes, improve medical quality, and provide safer, more efficient, and more convenient medical services for the broad population of chest pain patients. At the same time, it will continue to play a leading and exemplary role as a regional chest pain center, driving surrounding medical institutions to jointly enhance their treatment capabilities for chest pain patients and contribute to the development of regional cardiovascular disease prevention and treatment.
— Excerpted from Hebei News Network, 10 December 2024




